BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 998 filers reported holding BAXTER INTL INC in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $342,000 | +23.5% | 4,212 | 0.0% | 0.01% | +20.0% |
Q4 2018 | $277,000 | -16.1% | 4,212 | -1.5% | 0.01% | -16.7% |
Q3 2018 | $330,000 | -22.5% | 4,277 | -25.8% | 0.01% | -25.0% |
Q2 2018 | $426,000 | +10.6% | 5,768 | -2.5% | 0.01% | +14.3% |
Q1 2018 | $385,000 | +0.8% | 5,915 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $382,000 | -6.1% | 5,915 | -8.8% | 0.01% | -11.1% |
Q3 2017 | $407,000 | +3.6% | 6,488 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $393,000 | +10.4% | 6,488 | -5.4% | 0.01% | 0.0% |
Q1 2017 | $356,000 | +15.6% | 6,859 | -1.3% | 0.01% | -10.0% |
Q4 2016 | $308,000 | -5.8% | 6,948 | +1.3% | 0.01% | +11.1% |
Q3 2016 | $327,000 | -17.2% | 6,862 | -21.1% | 0.01% | -25.0% |
Q2 2016 | $395,000 | -88.3% | 8,696 | -89.4% | 0.01% | -89.7% |
Q1 2016 | $3,366,000 | -51.4% | 81,938 | -54.9% | 0.12% | -57.7% |
Q4 2015 | $6,932,000 | +4.0% | 181,695 | -10.5% | 0.27% | -3.5% |
Q3 2015 | $6,668,000 | -56.7% | 202,978 | -7.7% | 0.28% | -56.7% |
Q2 2015 | $15,382,000 | -12.3% | 219,961 | -14.1% | 0.66% | -14.1% |
Q1 2015 | $17,538,000 | -1.4% | 256,031 | +5.4% | 0.76% | -8.6% |
Q4 2014 | $17,795,000 | +16.8% | 242,805 | +14.4% | 0.84% | +6.6% |
Q3 2014 | $15,229,000 | +9.8% | 212,193 | +10.6% | 0.78% | -2.6% |
Q2 2014 | $13,866,000 | +23.4% | 191,790 | +25.6% | 0.80% | +5.0% |
Q1 2014 | $11,236,000 | +160.1% | 152,710 | +145.9% | 0.77% | +136.0% |
Q4 2013 | $4,320,000 | +323.5% | 62,107 | +289.1% | 0.32% | +265.2% |
Q3 2013 | $1,020,000 | +110.3% | 15,962 | +128.0% | 0.09% | +78.0% |
Q2 2013 | $485,000 | – | 7,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |